Huang Hui, Li Yongning, Dai Yabin, Zhang Yuefen, Lu Qiaomei, Xu Qiaoxin, Zhang Yulin
Fu Jian Health College, Fuzhou, China.
Testing Center of Fuzhou University, Fuzhou, China.
Biomed Chromatogr. 2021 Dec;35(12):e5216. doi: 10.1002/bmc.5216. Epub 2021 Jul 28.
A novel approach is presented to identify constituents with antileukemic properties in extracts of Indigo naturalis (Qingdai in Chinese). Target compounds (A , BC , and ABC ) that knocked out specific constituents displayed antileukemic effects in a total extract of I. naturalis and negative constituents (A , BC , and ABC ) that knocked out target compounds were separated, identified and knocked out by semipreparative liquid chromatography (semipreparative HPLC) and quadrupole time-of-flight mass spectrometer. Quantitative methods were used to evaluate the content of each knocked-out constituent in the total extract (D). Subsequently, interactions between the antileukemic effects of knocked-out constituents and D were screened and evaluated at the cellular level. Negative constituents including A (65.47% ± 1.20%), BC (54.61% ± 2.43%) and ABC (67.49% ± 3.28%) displayed a greater inhibitory effect than D (47.16% ± 0.072%), which was not knocked out after 24 h of incubation, whereas the target compounds had not superior. Target compounds may have caused an antagonistic effect on the corresponding negative constituents. After 48 h, inhibition of proliferation by D (75.48% ± 3.78%) increased compared with that by negative constituents, whereas the antagonistic effect of target components on negative constituents was diminished. This result may reflect competitive antagonism. Comparing the reactions after 24 and 48 h, the inhibitory ratio of ABC (79.29% ± 1.22%) in these knocked-out constituents and D was always the highest. With different concentrations tested after 48 h, ABC significantly increased the rate of apoptosis on K562 cells (P < 0.01), indicating that in addition to indirubin, tryptanthrin and isorhamnetin, other antileukemic constituents may be present. Our study presents an approach that is a truer reflection of the antileukemic effects of knocked-out constituents in I. naturalis supported by reference to pharmacodynamic actions and the quality of I. naturalis. The approach may be useful for the analysis of other herbal extracts found in traditional Chinese medicine.
本文提出了一种新方法,用于鉴定青黛提取物中具有抗白血病特性的成分。通过半制备液相色谱(半制备高效液相色谱)和四极杆飞行时间质谱仪分离、鉴定并剔除了敲除特定成分后显示抗白血病作用的目标化合物(A、BC和ABC)以及敲除目标化合物的阴性成分(A、BC和ABC)。采用定量方法评估总提取物(D)中每种被剔除成分的含量。随后,在细胞水平上筛选并评估被剔除成分与D的抗白血病作用之间的相互作用。阴性成分A(65.47%±1.20%)、BC(54.61%±2.43%)和ABC(67.49%±3.28%)显示出比D(47.16%±0.072%)更强的抑制作用,D在孵育24小时后未被剔除,而目标化合物则没有优势。目标化合物可能对相应的阴性成分产生了拮抗作用。48小时后,D(75.48%±3.78%)对增殖的抑制作用与阴性成分相比有所增加,而目标成分对阴性成分的拮抗作用减弱。这一结果可能反映了竞争性拮抗作用。比较24小时和48小时后的反应,这些被剔除成分和D中ABC的抑制率(79.29%±1.22%)始终最高。在48小时后测试不同浓度时,ABC显著提高了K562细胞的凋亡率(P<0.01),表明除了靛玉红、靛蓝和异鼠李素外,可能还存在其他抗白血病成分。我们的研究提出了一种方法,通过参考药效作用和青黛质量,更真实地反映了青黛中被剔除成分的抗白血病作用。该方法可能有助于分析中药中发现的其他草药提取物。